The Molecular Biological Mechanism of Hydrogen Therapy and Its Application in Spinal Cord Injury
Quan Hu,Yingxiao Li,Zhaochen Lin,Hao Zhang,Haoyue Chen,Cui Chao,Chuanliang Zhao
DOI: https://doi.org/10.2147/dddt.s463177
IF: 4.3188
2024-04-30
Drug Design Development and Therapy
Abstract:Quan Hu, 1, &ast Yingxiao Li, 2, &ast Zhaochen Lin, 3 Hao Zhang, 4 Haoyue Chen, 4 Cui Chao, 3 Chuanliang Zhao 5 1 Department of Neurosurgery, The Affiliated Taian City Central Hospital of Qingdao University, Tai'an City, Shandong, 271000, People's Republic of China; 2 Department of Gynecology, The Affiliated Taian City Central Hospital of Qingdao University, Tai'an City, Shandong, 271000, People's Republic of China; 3 Hydrogen Medical Research Center, The Affiliated Taian City Central Hospital of Qingdao University, Tai'an City, Shandong, 271000, People's Republic of China; 4 Department of Rehabilitation Medical Center, The Affiliated Taian City Central Hospital of Qingdao University, Tai'an City, Shandong, 271000, People's Republic of China; 5 Department of Orthopedics, the Affiliated Taian City Central Hospital of Qingdao University, Tai'an City, Shandong, 271000, People's Republic of China &astThese authors contributed equally to this work Correspondence: Chuanliang Zhao, Department of Orthopedics, The Affiliated Taian City Central Hospital of Qingdao University, Tai'an City, Shandong, 271000, People's Republic of China, Tel +8615621539631, Email Hydrogen, which is a novel biomedical molecule, is currently the subject of extensive research involving animal experiments and in vitro cell experiments, and it is gradually being applied in clinical settings. Hydrogen has been proven to possess anti-inflammatory, selective antioxidant, and antiapoptotic effects, thus exhibiting considerable protective effects in various diseases. In recent years, several studies have provided preliminary evidence for the protective effects of hydrogen on spinal cord injury (SCI). This paper provides a comprehensive review of the potential molecular biology mechanisms of hydrogen therapy and its application in treating SCI, with an aim to better explore the medical value of hydrogen and provide new avenues for the adjuvant treatment of SCI. Keywords: hydrogen, spinal cord injury, selective antioxidant, anti-inflammatory Hydrogen gas is abundant in the environment. Traditionally considered an inert gas, its role in living organisms has been largely overlooked. In 1975, American researchers first reported that high-pressure hydrogen gas could be used to treat squamous cell carcinoma in mice, which is possibly due to its antioxidant properties. 1 In 2007, Japanese scholars reported that the inhalation of 2% hydrogen gas could selectively scavenge hydroxyl radicals and peroxynitrite anions, thereby improving oxidative stress damage caused by cerebral ischemia‒reperfusion and reducing the cerebral infarction area in rats. This study sparked widespread interest in the medical field regarding the value of hydrogen in medical research. 2 Since that time, research on hydrogen therapy has gradually expanded to include diseases such as liver cancer, chronic inflammatory responses in hemodialysis, mitochondrial myopathy, metabolic syndrome, diabetes, rheumatoid arthritis, and pneumonia, thus achieving promising results. 3–6 Hydrogen is now recognized as being the fourth signaling gas molecule after Nitric Oxide (NO), Carbon monoxide (CO), and Hydrogen sulfide (H 2 S) and is considered a novel medical gas molecule. 7,8 This article aims to provide a comprehensive review of the potential molecular and biological mechanisms of hydrogen therapy, as well as its application in treating spinal cord injury (SCI), with the objective of better understanding the medical value of hydrogen and providing new avenues for the adjunctive treatment of SCI. SCI can be divided into two stages based on pathological changes: primary and secondary stages. Primary injury signifies irreversible mechanical damage causing tissue deformation or tearing, local blood supply disorders, neuronal and glial damage, local axonal truncation, and neuronal destruction. Secondary injury prompts immune system activation, thus leading to rapid microglial activation and the release of proinflammatory mediators such as NO, interleukin-1 beta (IL-1β), tumor necrosis factor-α (TNF-α), and interleukin-6 (IL-6). Cytokines produced by activated inflammatory cells, along with adhesion molecules and chemokines produced by damaged endothelial cells, promote the influx of neutrophils and monocytes into the injured spinal cord. This triggers an inflammatory response cascade that exacerbates SCI, thus ultimately leading to excitotoxicity, axonal demyelination, necrosis, glial scar formation, degeneration, and cell death of damaged cells. 9 Currently, treatment methods for SCI are rapidly evolving, with some methods transitioning from laboratory to clinical trials.<sup -Abstract Truncated-
pharmacology & pharmacy,chemistry, medicinal